Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Margarita, Malasa"'
Autor:
Georg Nickenig, Adrian Attinger-Toller, Karl-Heinz Kuck, Florian Deuschl, Gilbert H.L. Tang, Felix Kreidel, Ryan Kaple, Marco Ancona, Francesco Maisano, Kim A. Connelly, Azeem Latib, Christian Frerker, Margarita Malasa, Rebecca T. Hahn, Hannes Alessandrini, Alec Vahanian, Fabian Nietlispach, Martin B. Leon, Joerg Hausleiter, Shingo Kuwata, Joachim Schofer, Ulrich Schäfer, Maurizio Taramasso, Robert Schueler, Paolo Denti, Eric Brochet, Neil Fam, John G. Webb, Daniel Braun, Ermela Yzeiraj, A Englmaier, Alberto Pozzoli, Jean Michel Juliard, Tamim Nazif
Publikováno v:
JACC: Cardiovascular Interventions. 10:1982-1990
Objectives This study sought to develop a large, international registry to evaluate the diffusion of these approaches and investigate patient characteristics and initial clinical results. Background Several transcatheter tricuspid valve therapies are
Publikováno v:
Kardiologie up2date. 12:323-326
Publikováno v:
European Heart Journal. 37:849-853
Aim The aim of this study was to show technical principles and feasibility of transcatheter tricuspid valve repair by use of the MitraClip system. Methods and results Three consecutive patients were treated successfully for severe symptomatic Tricusp
Autor:
J Spillner, Maximilian Kütting, Ulrich Steinseifer, Margarita Malasa, Ruediger Autschbach, Andrea Amerini, Nima Hatam, Jan Roggenkamp, Desiree Pott
Publikováno v:
Zeitschrift für Herz-,Thorax- und Gefäßchirurgie. 27:361-365
Die Trikuspidalklappeninsuffizienz tritt am haufigsten aufgrund einer Dilatation des rechten Ventrikels, sekundar nach linksseitigen Herzerkrankungen, auf. Bis vor Kurzem wurde der Entwicklung von perkutanen Trikuspidalklappenprothesen wenig Aufmerks
Publikováno v:
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology. 12
A 60-year-old man was hospitalized with chronic right heart failure, ascites, and peripheral oedema. He had a history of ischaemic cardiomyopathy without need for revascularization, persistent atrial fibrillation, and renal failure. Echocardiography
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::073453a7101a0063e71cc95f502cbb53
https://www.zora.uzh.ch/id/eprint/123130/
https://www.zora.uzh.ch/id/eprint/123130/
Autor:
Martin Hildinger, Peter Isfort, Rüdiger Autschbach, Andrea Amerini, Margarita Malasa, Nima Hatam, Andreas Goetzenich, Desiree Pott, Jan Spillner, L. Tewarie
Publikováno v:
Interactive cardiovascular and thoracic surgery. 19(3)
OBJECTIVES: Interventional treatment of tricuspid valve disease has so far received little attention due to the anatomical challenges in a thrombogenic surrounding. In the present study, we present an imaging-based, personalized interventional approa
Autor:
Andrea Luigi, Amerini, Margarita, Malasa, Nima, Hatam, Yara, Safi, Ulrich, Steinseifer, Andreas, Mahnken, Andreas, Goetzenich, Marcus, Haushofer, Martin, Hildinger, Rudiger, Autschbach, Angelo, Carpi, Jan Wilhelm, Spillner
Publikováno v:
Frontiers in bioscience (Elite edition). 5(2)
Currently, there are no fully developed interventional approaches for the treatment of tricuspid regurgitation (TR). The aim of this study was to evaluate the feasibility of orthotopic interventional placement of a biological prosthetic valve in the
Autor:
Nima Hatam, Ute Urban, Jan Roggenkamp, Desiree Pott, Margarita Malasa, Rüdiger Autschbach, Maximilian Kuetting, Jan Spillner, Andrea Amerini, Ulrich Steinseifer
Publikováno v:
Journal of the American College of Cardiology. 60(17)
Autor:
Nima Hatam, Yara Safi, Desiree Pott, Andrea Amerini, Ulrich Steinseifer, Margarita Malasa, Jan Roggenkamp, Rüdiger Autschbach, Maximilian Kütting, Jan Spillner, Ute Urban
Publikováno v:
ASAIO journal (American Society for Artificial Internal Organs : 1992). 58(6)
Tricuspid valve regurgitation mostly occurs as result of dilation of the right ventricle, secondary to left heart valve diseases. Until recently, little attention has been given to the development of percutaneous therapeutic tools exclusively designe